Sven Karlsson

Venture Partner


Sven is a Venture Partner at AlleyCorp, where he identifies new investment opportunities and supports portfolio companies. He is a biotech entrepreneur and a co-founder of PlateletBio, an allogeneic cell therapy platform company leveraging platelet biology to treat autoimmune diseases. He’s passionate about entrepreneurship and supporting founders as they navigate the rollercoaster from idea to product. In addition to his work with AlleyCorp, Sven currently serves as an advisor to 64x Bio, Luna Genetics, Gate Science, Mulberry Biotherapeutics, and other companies currently in stealth mode.

Sven is a CFA Charterholder and graduated with an MBA from The Stern School of Business at NYU, where he was the recipient of the Dean’s Award for Outstanding Scholarship. He completed his undergraduate studies at the Cornell University College of Engineering.